Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Viviane MongesDirector | PharvarisPHVS | Open-market sale | 09/23 | 09/25 | 11,969 sh | $33.05 | $395,523.98 | −68.5% |
PharvarisPHVS | Open-market sale | 09/22 | 09/24 | 800 sh | $36.19 | $28,952 | −0.7% | |
David W. NassifCFO / Clo | PharvarisPHVS | Open-market sale | 09/21 | 09/23 | 6,000 sh | $36.47 | $218,800.8 | −5.0% |
PharvarisPHVS | Open-market sale10b5-1 plan | 06/29 | 06/29 | 2,400 sh | $35.10 | $84,240 | −0.7% | |
PharvarisPHVS | Open-market sale10b5-1 plan | 06/25–06/26 | 06/29 | 29,700 sh3 trades | $34.30avg. | $1,018,726 | −31.2% | |
PharvarisPHVS | Open-market sale10b5-1 plan | 06/25 | 06/29 | 4,600 sh2 trades | $35.12avg. | $161,552 | No record | |
Peng LuChief Medical Officer | PharvarisPHVS | Open-market sale10b5-1 plan | 06/18 | 06/23 | 300 sh | $34.00 | $10,200 | −0.5% |
PharvarisPHVS | Open-market sale10b5-1 plan | 06/15 | 06/17 | 2,291 sh2 trades | $31.07avg. | $71,176.55 | −1.7% | |
Anna NijdamPrincipal Accounting Officer | PharvarisPHVS | Open-market sale | 06/04 | 06/08 | 2,670 sh | $30.87 | $82,422.9 | −5.5% |
PharvarisPHVS | Open-market sale | 05/21–05/22 | 05/26 | 7,330 sh2 trades | $30.71avg. | $225,068.14 | −13.0% | |
David W. NassifCFO / Clo | PharvarisPHVS | Open-market sale | 05/21 | 05/26 | 10,000 sh | $30.31 | $303,100 | −7.7% |
Viviane MongesDirector | PharvarisPHVS | Open-market sale | 05/21 | 05/26 | 9,667 sh | $30.29 | $292,813.43 | −63.7% |
Elisabeth BjorkDirector | PharvarisPHVS | Open-market sale10b5-1 plan | 05/20 | 05/22 | 10,000 sh | $29.32 | $293,200 | −39.7% |
Berndt ModigCEO | PharvarisPHVS | Open-market sale10b5-1 plan | 05/18 | 05/20 | 2,292 sh | $29.22 | $66,972.24 | −1.6% |
PharvarisPHVS | Open-market sale | 05/15 | 05/19 | 10,000 sh2 trades | $29.83avg. | $298,253.33 | −48.8% | |
Wim SouverijnsChief Commercial Officer | PharvarisPHVS | Open-market sale10b5-1 plan | 05/15 | 05/19 | 10,000 sh | $29.92 | $299,200 | −18.1% |
Stefan Andreas AbeleChief Technical Ops Officer | PharvarisPHVS | Open-market sale | 05/15 | 05/19 | 8,748 sh | $29.82 | $260,865.36 | −19.9% |
PharvarisPHVS | Open-market sale10b5-1 plan | 05/01 | 05/05 | 14,166 sh2 trades | $30.17avg. | $427,366.68 | −17.7% | |
PharvarisPHVS | Open-market sale10b5-1 plan | 04/29–04/30 | 05/01 | 18,733 sh2 trades | $30.20avg. | $565,813.98 | −22.1% | |
PharvarisPHVS | Open-market sale10b5-1 plan | 04/29–04/30 | 05/01 | 48,300 sh5 trades | $30.23avg. | $1,460,152 | No record |
